Trials / Completed
CompletedNCT00429377
Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
Phase 3 Study of Tacrolimus(FK506)for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 64 (planned)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 16 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study consists of a 28-week placebo-controlled double-blind inter-group efficacy study in steroid refractory Lupus Nephritis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus |
Timeline
- Start date
- 2003-06-01
- First posted
- 2007-01-31
- Last updated
- 2007-01-31
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00429377. Inclusion in this directory is not an endorsement.